Fidelity Advisor Health Care Fund - Class Z (FIKCX)
| Fund Assets | 3.25B |
| Expense Ratio | 0.59% |
| Min. Investment | $0.00 |
| Turnover | 52.00% |
| Dividend (ttm) | 7.46 |
| Dividend Yield | 11.68% |
| Dividend Growth | 8.84% |
| Payout Frequency | n/a |
| Ex-Dividend Date | Dec 26, 2025 |
| Previous Close | 62.84 |
| YTD Return | -1.71% |
| 1-Year Return | 5.66% |
| 5-Year Return | 13.49% |
| 52-Week Low | 51.73 |
| 52-Week High | 67.86 |
| Beta (5Y) | n/a |
| Holdings | 133 |
| Inception Date | Oct 2, 2018 |
About FIKCX
Fidelity Advisor Health Care Fund Class Z is an actively managed mutual fund specializing in the health care sector. The fund's primary objective is capital appreciation, and it achieves this by investing at least 80% of its assets in the securities of companies that are principally engaged in the design, manufacture, or sale of products or services used for or in connection with health care or medicine. This includes businesses across various subsectors such as pharmaceuticals, biotechnology, medical equipment, and health care services. Established in 2018, the fund is managed by Fidelity, a leading provider of investment management services. The portfolio typically consists of a diversified selection of growth and value stocks, and as of the latest available data, it holds over 100 different positions within the health care industry. The fund is notable for its relatively low expense ratio in its class, making it a cost-effective choice for investors seeking exposure to health care equities. With assets totaling several billion dollars, it plays a significant role for investors aiming to capture growth opportunities in one of the most dynamic and essential sectors of the global economy.
Performance
FIKCX had a total return of 5.66% in the past year, including dividends. Since the fund's inception, the average annual return has been 12.41%.
Top 10 Holdings
39.26% of assets| Name | Symbol | Weight |
|---|---|---|
| Eli Lilly and Company | LLY | 6.76% |
| Danaher Corporation | DHR | 6.30% |
| Boston Scientific Corporation | BSX | 5.85% |
| Penumbra, Inc. | PEN | 3.90% |
| argenx SE | ARGX | 3.18% |
| AbbVie Inc. | ABBV | 3.01% |
| CVS Health Corporation | CVS | 2.64% |
| UCB SA | UCB | 2.61% |
| Ascendis Pharma A/S | ASND | 2.51% |
| Alnylam Pharmaceuticals, Inc. | ALNY | 2.50% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Dec 26, 2025 | $7.462 | Dec 29, 2025 |
| Dec 26, 2024 | $6.856 | Dec 27, 2024 |
| Dec 17, 2021 | $4.207 | Dec 20, 2021 |
| Dec 18, 2020 | $4.091 | Dec 21, 2020 |
| Dec 20, 2019 | $0.374 | Dec 23, 2019 |
| Dec 7, 2018 | $2.218 | Dec 10, 2018 |